Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy

NCT01864486 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-10-17

No results posted yet for this study

Summary

This study evaluates the safety and effectiveness of the Intelligent Retinal Implants System (IRIS V1)

Conditions

Interventions

DEVICE

Intelligent Retinal Implant System

Sponsors & Collaborators

  • Science Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2017-10-13
Completion
2017-10-13

Countries

  • Austria
  • France
  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01864486 on ClinicalTrials.gov